Cargando…

Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study

To promote symptom relief from acid-related diseases, a medicine with a rapid-onset effect is ideal. The aim of this study was to investigate the early inhibitory effect on gastric acid secretion after a single oral administration of vonoprazan, which represents a new class of proton pump inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohkuma, Kanji, Iida, Hiroshi, Inoh, Yumi, Kanoshima, Kenji, Ohkubo, Hidenori, Nonaka, Takashi, Fujita, Koji, Kusakabe, Akihiko, Inamori, Masahiko, Nakajima, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064815/ https://www.ncbi.nlm.nih.gov/pubmed/30087548 http://dx.doi.org/10.3164/jcbn.17-128

Ejemplares similares

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a (13)C breath test
por: Kanoshima, Kenji, et al.
Publicado: (2017)

Assessment of colonic contents in patients with chronic constipation using MRI
por: Inoh, Yumi, et al.
Publicado: (2018)

Can sedation using a combination of propofol and dexmedetomidine enhance the satisfaction of the endoscopist in endoscopic submucosal dissection?
por: Nonaka, Takashi, et al.
Publicado: (2018)

Lubiprostone improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled 2-way crossover study
por: Matsuura, Mizue, et al.
Publicado: (2017)

Lubiprostone Decreases the Small Bowel Transit Time by Capsule Endoscopy: An Exploratory, Randomised, Double-Blind, Placebo-Controlled 3-Way Crossover Study
por: Matsuura, Mizue, et al.
Publicado: (2014)

Can magnifying endoscopy with narrow-band imaging discriminate between carcinomas and low grade adenomas in gastric superficial elevated lesions?
por: Nonaka, Takashi, et al.
Publicado: (2016)

Early effects of acotiamide or mosapride intake on gastric emptying: a randomized 3-way crossover study using the (13)C breath test
por: Kaai, Megumi, et al.
Publicado: (2021)

Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
por: Ashida, Kiyoshi, et al.
Publicado: (2018)

Effect of Lansoprazole on the Control of the Intragastric pH in a Patient with Short Bowel Syndrome
por: Yoshioka, Masato, et al.
Publicado: (2019)

Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test
por: Nonaka, Takashi, et al.
Publicado: (2013)

Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study
por: Ida, Tomonori, et al.
Publicado: (2017)

Epidemiology and Clinical Experience of Chronic Intestinal Pseudo-Obstruction in Japan: A Nationwide Epidemiologic Survey
por: Iida, Hiroshi, et al.
Publicado: (2013)

Vonoprazan versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-effectiveness Analysis in Japan
por: Habu, Yasuki
Publicado: (2019)

Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs
por: Tolbert, M.K., et al.
Publicado: (2016)

Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others
por: Nakamura, Masahiko, et al.
Publicado: (2007)

Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers
por: Takahashi, Kazuya, et al.
Publicado: (2016)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs
por: Hedges, Katherine, et al.
Publicado: (2019)

Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015)

Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values
por: Iida, Hiroshi, et al.
Publicado: (2009)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
por: Iida, Hiroshi, et al.
Publicado: (2012)

Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study
por: Ban, Hiromitsu, et al.
Publicado: (2021)

Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial
por: Kawai, Daisuke, et al.
Publicado: (2021)

Mosapride Accelerates the Delayed Gastric Emptying of High-Viscosity Liquids: A Crossover Study Using Continuous Real-Time (13)C Breath Test (BreathID System)
por: Sakamoto, Yasunari, et al.
Publicado: (2011)

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
por: Xiao, Yinglian, et al.
Publicado: (2020)

Postpyloric decompression tube placement through a gastrostomy for malignant bowel obstruction
por: Kurita, Yusuke, et al.
Publicado: (2013)

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study
por: Zhan, Xian-Bao, et al.
Publicado: (2012)

Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
por: Mizokami, Yuji, et al.
Publicado: (2018)

Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015)

Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: The OITA-GF study 2
por: Tamura, Akira, et al.
Publicado: (2013)

Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis
por: Kent, Jeffery D., et al.
Publicado: (2014)

Investigation of the Local Recurrence Rate after Colorectal Endoscopic Mucosal Resection: Is Incomplete Polyp Resection Really a Clinically Important Problem? Analysis of the Rationale for the “Resect and Discard” Strategy
por: Arimoto, Jun, et al.
Publicado: (2019)

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials
por: Miwa, H., et al.
Publicado: (2016)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

A method for improving the properties of famotidine
por: Zhao, Yongfeng, et al.
Publicado: (2023)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

Is the Completion Time of a Questionnaire a Pivotal Factor When Proving Feasibility?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c04p4m9omversgdhof6v1gbjo3